Alpha Tau Medical Ltd. Ordinary Shares
Symbol: DRTS (NASDAQ)
4.10
▲ (1.36%) 0.055
Company Description:
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
Key Stats
- Today's Open: $4.07
- Today's High: $4.16
- Today's Low: $4.01
- Today's Volume: 11.52K
- Yesterday Close: $4.04
- Yesterday High: $4.27
- Yesterday Low: $3.97
- Yesterday Volume: 38.43K
- Last Min Volume: 100
- Last Min High: $4.095
- Last Min Low: $4.095
- Last Min VWAP: $4.095
Company Profile
- Name: Alpha Tau Medical Ltd. Ordinary Shares
- Website: https://www.alphatau.com
- Listed Date: 2022-03-08
- Location: ,
- Market Status: Active
- CIK Number: 0001871321
- SIC Code:
- SIC description:
- Market Cap: $357.18M
- Round Lot: 100
- Outstanding Shares: 85.04M
- Asset Type: CS
RECENT FILINGS FOR DRTS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-21 | 6-K | View |
| 2025-10-01 | 144 | View |
| 2025-09-02 | 6-K | View |
| 2025-08-27 | 6-K | View |
| 2025-08-11 | 6-K | View |
| 2025-07-24 | SCHEDULE 13G | View |
| 2025-07-02 | EFFECT | View |
| 2025-06-30 | CORRESP | View |
| 2025-06-27 | UPLOAD | View |
| 2025-06-23 | F-3 | View |
| 2025-06-17 | 6-K | View |
| 2025-05-28 | 6-K | View |
| 2025-05-19 | 6-K | View |
| 2025-05-13 | 6-K | View |
| 2025-05-12 | 6-K | View |
| 2025-05-06 | 6-K | View |
| 2025-05-01 | SCHEDULE 13D | View |
| 2025-04-28 | 6-K | View |
| 2025-04-28 | 424B5 | View |
| 2025-04-02 | 6-K | View |
Latest News on DRTS